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Available online 31 January 2018Long non-coding RNAs (lncRNAs) are currently recognized as crucial players in nervous system development,
function and pathology. In Amyotrophic Lateral Sclerosis (ALS), identification of causative mutations in FUS
and TDP-43 or hexanucleotide repeat expansion in C9ORF72 point to the essential role of aberrant RNA metab-
olism in neurodegeneration. In this study, by taking advantage of an in vitro differentiation system generating
mouse motor neurons (MNs) from embryonic stem cells, we identified and characterized the long non-coding
transcriptome of MNs. Moreover, by usingmutant mouse MNs carrying the equivalent of one of themost severe
ALS-associated FUS alleles (P517L), we identified lncRNAs affected by this mutation. Comparative analysis with
humanMNs derived in vitro from induced pluripotent stem cells indicated that candidate lncRNAs are conserved
between mouse and human. Our work provides a global view of the long non-coding transcriptome of MN, as a
prerequisite toward the comprehension of the still poorly characterized non-coding side ofMNphysiopathology.







ALS1. Material and methods
1.1. RNA-Seq and bioinformatics analysis
TruSeq Stranded Total RNA Library Prep Kit with Ribo-Zero treat-
ment (Illumina) was used to obtain sequencing libraries from total
RNA extracted from sorted GFP(+) MNs differentiated from three dif-
ferent mESC clones (C57BL/6J strain). The sequencing reaction, which
produced 100 nucleotide long paired end reads, was performed on an
Illumina Hiseq 2500 Sequencing system.yotrophic Lateral Sclerosis;MN,
ence@Sapienza, Istituto Italiano







thology of CNR, Rome, Italy.
. This is an open access article underTrimmomatic software (Bolger et al., 2014) was used to remove
adapter sequences and poor quality bases from raw reads; reads
whose length after trimming was b30 nt were discarded. We also fil-
tered out reads aligning to rRNAs, tRNAs, snRNAs, snoRNAs and
other small non-coding species which resulted to be overrepresented
according to FastQC software (available online at http://www.
bioinformatics.babraham.ac.uk/projects/fastqc); this first alignment
was performed using Bowtie 2 software (Langmead and Salzberg,
2012). Preprocessed reads were aligned to GRCm38 mouse genome
and Ensembl transcriptome (Flicek et al., 2014) using TopHat2 (Kim
et al., 2013) with parameters -i 50 –library-type fr-firststrand; to esti-
mate mean and variance of inner distance distribution, which are re-
quired by TopHat2 software, we previously aligned reads to a non-
redundant set of mRNA sequences derived from Ensembl 77 gene an-
notation using BWA software (Li and Durbin, 2010), then we calcu-
lated mean and variance of inner distance distribution from aligned
read pairs whose inner distance was within interval [Q1 − 2(Q3 −
Q1), Q3 + 2(Q3 − Q1)] (Q1 = first quartile, Q3 = third quartile).
Reads mapping to mitochondrial genome were filtered off using
Samtools software (Li et al., 2009). Cuffdiff 2 software (Differential
analysis of gene regulation at transcript resolution with RNA-seq)
was used to perform differential expression analysis.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
173S. Biscarini et al. / Stem Cell Research 27 (2018) 172–179Heatmap of differentially expressed lincRNAs was generated using
heatmap3 R package (Zhao et al., 2014) from log2 transformed FPKM
values.1.2. Cell cultures
Spinal motor neurons (MNs) were differentiated from mESCs HB9::
GFP Fus+/+, Fus−/− or Fus P517L/P517L (C57BL/6J strain; one clone for
each genetic background) as described in (Errichelli et al., 2017;
Wichterle and Peljto, 2008), by culturing embryoid bodies (EBs) in
ADFNK medium, complemented with B27 Supplement, Retinoic Acid
(RA) and Smoothened Agonist (SAG).1.3. Fluorescence-activated cell sorting (FACS)
The differentiated mixed population was dissociated by Papain Dis-
sociation system (Worthington). Cells were resuspended in PBS with-
out Ca++Mg++ complemented with 2.5% Horse Serum, 0.4%
Glucose, DNAseI (50 μg/ml), containing 2% B27 Supplement and sorted
for GFP expression using a FACSAriaIII (Becton Dickinson, BD Biosci-
ences) equippedwith a 488 nm laser and FACSDiva software (BDBiosci-
ences version 6.1.3). The analysis was based on FlowJo software (Tree
Star). An aliquot of each collected sample was evaluated for purity
resulting N99%.
Highly purifiedMNswere plated on 0.01%poly-L-ornithine, 10 μg/ml
natural mouse laminin (Sigma-Aldrich) coated dishes, in MN medium
(Neurobasal medium, 2% horse serum, 1% B27, 1% Pen/Step, 0.25% 2-
mercaptoethanol, 0.25% Glutamax, 0.025 mM L-glutamic acid) supple-
mented with 10 ng/ml BDNF, 10 ng/ml GDNF, 10 ng/ml CNTF,
10 ng/ml NT3 (ThermoFisher) and ROCK-inhibitor (20 μM) for the
first 48 h.1.4. RNA preparation and analysis
Total RNA from cells was extracted with the Quick RNA MiniPrep
(Zymo Research) and retrotranscribed with SuperScript VILO (Life
Technologies). The real-time qRT-PCR analysis was performed with
SYBR Green Power-UP (Life Technologies) using the housekeeping
geneAtp5o (ATP synthase, H+ transporting,mitochondrial F1 complex,
O subunit) as internal control.1.5. Cellular fractionation
At the end of differentiation, the mixed cell population was dissoci-
ated as for FACS analysis and plated on poly-L-ornithine/laminin-coated
dishes. After three more days of culture, cells were washed with PBS
without Ca++Mg++, 100 μl of buffer A (Tris 20 mM pH 8.0, NaCl
10 mM, MgCl2 3 mM, NP40 (IGEPAL) 0,10%, EDTA 0,2 mM, DTT 1 mM,
Protease inhibitor cocktail 1×, Ribolock 1×) were added and cells
were scraped, transferred to a 1,5 ml tube and incubated on ice for
5 min. Nuclei were pelleted 400 ×g 5 min at 4 °C. The supernatant, cor-
responding to the cytoplasmic fraction was stored on ice. The nuclear
pellet was washed twice with 50 μl of buffer A. RNA was then extracted
adding600 μl of RNA Lysis buffer (QuickRNAMiniprep) to both fractions
as described in “RNA preparation and analysis”.1.6. Coding potential calculation
Coding potential calculation was performed as recommended by
CPC (http://cpc2.cbi.pku.edu.cn/) and CPAT (http://lilab.research.bcm.
edu/cpat/index.php) online tools.1.7. Statistical analysis
Results are expressed asmeans±SD. Statistical differenceswere an-
alyzed by two-tailed Student's t-test. A P-value b 0.05was considered as
statistically significant. *P b 0.05, **P b 0.01, ***P b 0.001.
1.8. Oligonucleotides
Oligonucleotide sequences used in this study are listed in Table S1.
2. Introduction
Long non-coding RNAs (lncRNAs) are a heterogeneous class of non
proteinogenic molecules longer than 200 nt which, in the last decades,
have been shown to play several roles in cellular biology both in physi-
ological and pathological conditions (Ponting et al., 2009).
Current views describe lncRNAs as less expressed than mRNAs, but
showing high tissue specificity (Derrien et al., 2012); in particular,
among non-ubiquitous transcripts, 40% display brain-specific expres-
sion (Derrien et al., 2012), suggesting their relevant role in the nervous
system. Despite deep sequencing technologies promoted the annota-
tion process, uncovering an unexpected abundance of lncRNAs, very
few species have been functionally characterized so far (Briggs et al.,
2015). LncRNAs participate in various stages along the path fromplurip-
otent to differentiated cells; indeed they may act in the exit from
pluripotency (Guttman et al., 2011); guide neural fate choice driving
transcription factor localization (Ng et al., 2013; Vance et al., 2014), reg-
ulate local translation at synapses (Zalfa et al., 2003; Zhong et al., 2009)
or even influence neuronal excitability (Zhao et al., 2013). Some
lncRNAs have also been implicated in neurodegeneration, such as
BACE1AS, involved in amyloid plaques formation in Alzheimer disease
(Faghihi et al., 2008) or NEAT1, essential for paraspeckles formation
and over-expressed in Amyotrophic Lateral Sclerosis (ALS) (Nishimoto
et al., 2013).
ALS is an incurable adult-onset neurodegenerative disease, which af-
fects upper and lower motor neurons (MNs), and leads to paralysis and
death in 3–5 years from diagnosis (Taylor et al., 2016). Several genetic
alterations are associatedwith ALS (Renton et al., 2014), including caus-
ative mutations in FUS, TDP-43 and expansions in C9ORF72 point to the
essential role of aberrant RNA metabolism in ALS pathogenesis (Ling et
al., 2013). FUS is amultifunctional RNA/DNAbinding protein accounting
for 4% of familial ALS cases (Renton et al., 2014). FUS mutations fre-
quently result in protein mis-localization from the nucleus to the cyto-
plasm leading to pathological mechanisms linked to its loss and/or
gain-of-function in these cellular compartments (Vance et al., 2009);
this is the case for aggressive human mutation FUSP525L and its murine
equivalent, FusP517L.
In spite of the high number of neural-specific lncRNAs characterized
and the availability of several differentiation protocols for different neu-
ronal cell types, the profiling ofmotor neuronal lncRNA transcriptome is
still lacking; this has impaired a thorough understanding of the molec-
ular mechanisms underlying ALS.
To address these issues we combined the efficient generation of in
vitro-derivedmouseMNswith RNA-seq analysis to reveal aMN-specific
lncRNA signature. We identified several species showingMN-restricted
expression, conservation in human MNs and altered expression in Fus
depleted or mutated MNs.
3. Results
3.1. Identification of lncRNAs expressed in MN differentiation and
maturation
As previously described, mESCs harboring a GFP reporter under the
control of the MN-specific HB9 promoter can be efficiently differenti-
ated in vitro and FAC-sorted as MNs (Fig. S1A–D) (Errichelli et al.,
174 S. Biscarini et al. / Stem Cell Research 27 (2018) 172–1792017; Wichterle and Peljto, 2008; Wichterle et al., 2002). RNA-seq data
obtained from total RNA of GFP+ cells (GSE101097; Errichelli et al.,
2017) were compared with those of publicly available RNA-seq experi-
ments from undifferentiated mESCs (GSE43390; Williams et al., 2015).
We found 9644 genes differentially expressed (average FPKM in at
least one condition ≥ 1 and q-value b 0.05) between the two cell types
(Table S2); out of these, 469 encoded for bona fide lncRNAs (Table S2Fig. 1. Identification of lncRNAs expressed in MN differentiation. A. Heat-map of differenti
least one condition ≥ 1). B. qRT-PCR analysis of the 12 lncRNAs up-regulated during M
Differentiation time points are indicated as days below the diagrams (EBsn: embryoid
Atp5o expression levels. C. qRT-PCR analysis of the 12 lncRNAs in GFP+ (green bars) and
(MNs), set as 1, n = 3. Normalization vs Atp5o expression.and Fig. 1A). The family of lncRNAs up-regulated in MNs derived from
270 loci (Table S2) and includes some species already known to play
key roles in neurogenesis; among them, Miat (Aprea et al., 2013),
Rmst (Ng et al., 2013), Hotairm1 (Lin et al., 2011), Meg3, Rian, and
Mirg (Mo et al., 2015).
Up-regulated lncRNAswere ranked according to fold-change and fil-
tered for FPKM N 4. The neural expression of the top 40 hits wasally expressed lncRNAs between mESCs and MNs (q-value b 0.05; average FPKM in at
N differentiation. The expression is relative to levels detected in mESCs, set as 1.
bodies day n). Transcript names are indicated above each graph. Normalization vs
GFP- (black bars) cell populations. The expression is relative to levels in GFP+ cells
175S. Biscarini et al. / Stem Cell Research 27 (2018) 172–179assessed by analyzing publicly available longRNA-seq data from 26
mouse tissues (Stamatoyannopoulos et al., 2012), resulting in the iden-
tification of 12 transcripts with neural-restricted expression (Fig. S2A
and B). The 12 lncRNAs were strongly expressed in MNs (fold change
N 10) with a FPKM value between 4 and 151 (Fig. S3A). The differential
expression of the 12 lncRNAs was then validated through qRT-PCR on
RNA from mESCs and GFP+ MNs immediately after sorting or after six
additional days of maturation (Fig. S3B). For all the 12 lncRNAs weFig. 2.Molecular characterization of selected lncRNAs. A. Codogeneity graph displaying, for each
from Coding Potential Calculator (CPC, x-axis) and Coding Potential Assessment tool (CPAT, y-a
transcript 1 (HBA-A1-01) represents the coding transcript control, HOTAIR the non-coding tran
as percentage; a nuclear control (sno55 RNA) and a cytoplasmic control (Gapdh mRNA) are als
iPSCs. Top graph displays the expression of differentiation markers: Oct4 (stem cells), Pax6 (MN
iPSCs, set as 1. Normalization vs Atp5o expression.were able to confirm the up-regulation in MNs. Notably, three species
(2610316D01Rik, 5330434G04Rik and Gm26871) maintained or even
increased their expression upon further maturation, whereas other
transcripts (Haglr and E130006D01Rik) showed a drastic drop in ex-
pression after six additional days of culture (Fig. S3B).
We analyzed the expression profile of the 12 lncRNAs during differ-
entiation, in order to identify transcripts expressed when progenitor
and post-mitotic MNs were specified (Fig. 1B). Most of the 12transcript variant of each gene analyzed (reported above each diagram), the coding score
xis). Non-coding scores are b0 for CPC and b0,4 for CPAT. Hemoglobin alpha, adult chain 1
script control. B. RNA sub-cellular localization analysis: transcript distribution is expressed
o shown. C. Expression profile of selected lncRNAs during human MN differentiation from
progenitors), HB9, CHT1 and Lhx3 (MNs). LncRNA expression is relative to expression in
176 S. Biscarini et al. / Stem Cell Research 27 (2018) 172–179transcripts were initially expressed in the transition from neural pro-
genitor (pN) to MN progenitor (pMN) stages, as defined by the expres-
sion of Pax6 and Olig2 or HB9 and ChAT respectively (Fig. S1C).
Interestingly A730046J19Rik showed a marked up-regulation coinci-
dent with MNs specification (Fig. 1B).
MN-specificity was further tested by analyzing lncRNA expression
levels in GFP+ versusGFP - cell populations. Several candidates showed
a MN-restricted expression, as confirmed by their absence in the GFP-
population (Fig. 1C), which mainly contains MN progenitors as well as
V1, V2 and V3 interneurons (Fig. S1D).
We select for further analysis Lhx1os, 5330434G04Rik (renamed as
LncMN-2) and A730046J19Rik (renamed as LncMN-3) for their MN-
enriched expression while 2610316D01Rik (renamed as LncMN-1) be-
cause of its interesting genomic localization (see below).
3.2. Selected lncRNA molecular characterization
To characterize Lhx1os, lncMN-1, lncMN-2 and lncMN-3 we started
by examining their genomic loci in order to determine i) the structure of
the gene, ii) the number of annotated splice variants, iii) the degree of
sequence conservation, iv) the presence of repetitive region in the
exons and v) the function of surrounding genes (Fig. S4A–D).
Lhx1os shows three splicing variants, producing transcripts between
524 and 599 nt in length and composed of 4 or 5 exons (Fig. S4A). This
gene is divergent to Lhx1, a transcript encoding a morphogenetic factor
of the LIM family involved in lateral MN differentiation (Alaynick et al.,
2011), head development and MN axon guidance (Hunter and Rhodes,
2005).
LncMN-1 has three splice variants giving rise to 664–924 nt and 7/9-
exons transcripts. This lncRNA is divergent to the Pcdh10 gene, which
codes for a protocadherin involved in motor neuronal cell adhesion
(Fig. S4B) (Machado et al., 2014).
LncMN-2 is an intergenic lncRNA transcribed in 4 splicing variants
composed of 4–5 exons with lengths ranging from 511 to 3545 nt
(Fig. S4C).
LncMN-3 is a 3-exons, 4707 nt long, intergenic ncRNA (Fig. S4D),
characterized by an exceptionally high sequence conservation in mam-
mals (BLAT search identifies a non-continuous sequence of 1217 nt
showing 87,4% base conservation; Fig. S5).
The non-coding nature of the four species was assessed through the
Coding Potential Calculator (CPC) and Coding Potential Assessment Tool
(CPAT). ConsideringHemoglobin alpha, adult chain 1 transcript 1 (HBA-
A1-01) and HOTAIR as coding and non-coding controls respectively, we
could annotate the four hits as non-coding molecules (Fig. 2A).Fig. 3. LncRNA expression in FUS-ALS MNs. A. qRT-PCR analysis of selected lncRNAs in FusP51
Normalization vs Atp5o expression levels. One clone for each genetic background analyzed. B.
MNs (wt, black bars), set as 1; n = 3. Normalization vs Atp5o expression levels. One clone forConcerning lncMN-3, despite the bioinformatics analysis points to its
non-coding nature, the presence of an ORF of 267 nt may suggest this
lncRNA is a member of the emerging class of bifunctional RNAs, which
display independent functions for the transcript and the encoded pro-
tein (Andres-Pablo et al., 2017).
Further characterization of their sub-cellular localization indicated
that, with the exception of lncMN-2, which is almost equally distrib-
uted, the three lncRNAs are 70–80% cytoplasmic (Fig. 2B).
Amongour candidates, the only hitwith high sequence conservation
in human is lncMN-3 (Fig. S5); however, all four RNAs show synteny
conservation in human (orthologue transcripts: RP11-445F12.1, RP11-
9G1.3, MIR325HG, LINC00890). In order to assess the motor neuronal
expression of human counterparts, we took advantage of an in vitro sys-
tem to convert human iPSCs into MNs (De Santis et al., 2017; Errichelli
et al., 2017; Hill et al., 2016). Similarly to themurine system, the human
cell line contains a HB9::GFP cassette that enables the purification of
MNs. Fig. 2C shows that three species increased their expression during
human in vitroMN differentiation mimicking the situation observed in
mouse. Also in this case, the expression peak paralleled the expression
of markers of progenitor and post-mitotic MNs. LncMN-3 drops at MN
progenitor stage and successively rises back to iPSC level (Fig. 2C).
3.3. LncRNA de-regulation in mouse FUS-ALS in vitro model
Considering that ALS is characterized by the specific loss of MNs and
given that FUSmutations point to a relevant role of RNA dysmetabolism
in neurodegeneration (Ling et al., 2013), we investigated whether the
lncRNAs we identified showed any change in expression in an in vitro
model of FUS-ALS. By analyzing RNA expression in differentiated
FusP517L/P517L MNs we found that, compared to Fus+/+ MNs, Lhx1os
was up-regulated (fold change 2,5), while lncMN-1 and lncMN-2 were
down-regulated (fold change 0,5 and 0,8 respectively; Fig. 3A). No alter-
ation was instead observed for lncMN-3 (Fig. 3A).
To discriminate whether Lhx1os, lncMN-1 and lncMN-2 altered ex-
pression in FusP517L/P517L depended on Fus gain- or loss-of-function,
we analyzed their levels in FUS knock-out MNs (Fus−/−). Notably, in
these cells the three lncRNAs exhibited the same alterations observed
in FusP517L/P517L MNs (Fig. 3B), indicating a loss-of-functionmechanism.
LncMN-3 expressionwas not analyzed in Fus−/−MNsince itwas not af-
fected by FUS mutation.
Given that Lhx1os and lncMN-1 are divergent from twoprotein-cod-
ing genes (PCGs) involved in neuronal physiology, we investigated the
behavior of the PCGs during differentiation and we observed a strong
co-regulation of the two divergent transcripts in both mouse and7L/P517L MNs (homo, gray bars), relative to Fus+/+ MNs (wt, black bars), set as 1; n = 3.
qRT-PCR analysis of specific lncRNAs in Fus−/−MNs (ko, striped bars), relative to Fus+/+
each genetic background analyzed.
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deregulation of the neighboring lncRNAs also upon FUS mutation (Fig.
4B), indicating a co-regulated response to Fus for these divergent tran-
scriptional units.
4. Discussion
Transcriptome sequencing of bulk cell populations has led to the
idea that lncRNAs are poorly expressed. However recent single cell anal-
ysis has revealed that lncRNAs are expressed at levels comparable to
mRNAs (Liu et al., 2016). In this work, we analyzed the long non-coding
transcriptome of FAC-Sorted mESC-derived MNs and identified a set of
strongly induced lncRNAs. Interestingly, the expression of a subgroup
of these was activated in the late stages of differentiation, when post-
mitotic MNs are specified, possibly indicating a role for these molecules
not only in MN differentiation but also in their mature physiology. No-
tably, our candidates are conserved by sequence and/or synteny in
human and are expressed in MNs derived from human iPSCs. Consider-
ing the generally poor conservation of this class of transcripts, it is there-
fore likely that the identified species might be involved in some
conserved and critical MN function. While LncMN-2 and LncMN-3 are
located in intergenic regions, Lhx1os and LncMN-1 are transcribed in
opposite direction from PCGs involved in MN physiology. Interestingly,Fig. 4. Expression of divergent lncRNAs/PCG pairs. A. qRT-PCR analysis of divergent lncRNAs (
panels) or iPSC (right panels) differentiation to MNs. Expression in stem cells was set as 1. No
and LncMN-1) and their neighboring genes (Lhx1 and Pcdh10) in FusP517L/P517L MNs (hom
expression levels.we observed a strong co-regulation of the divergent transcripts in both
human andmousemodels. Recent work highlighted a non-random dis-
tribution of lncRNAs inmammalian genomeswith20% of thembeingdi-
vergent from PCGs. Moreover, a higher level of expression correlation
was observed in the case of lncRNAs divergent from PCGs compared
to pairs of neighboring PCGs (Luo et al., 2016). Interestingly, Gene On-
tology term analysis indicated that PCGs divergent from lncRNA genes
are enriched for transcription factors involved in pattern specification
(Luo et al., 2016). In our case, Lhx1 (PCG of Lhx1os) is a LIM-domain
containing transcription factor involved in urogenital, kidney, liver,
and nervous system development but in adult tissues its expression is
restricted to the kidney and the brain (Hunter and Rhodes, 2005);
moreover, insertions/deletions in the chromosomal region harboring
this gene have been associated with several cases of mental retardation
(OMIM).With respect to theMN physiology, the expression of Lhx1 de-
termines the specification of laterally positioned Lateral Motor Column
MNs (lLMC) which are the MNs projecting to the dorsal muscles of the
limbs (Tsuchida et al., 1994). Lhx1 is also known to control the expres-
sion of adhesionmolecules, therefore participating in the establishment
of axon trajectory (Kania and Jessell, 2003).
Another very interesting candidate for the study of MN function is
the PCG antisense to LncMN-1, Pcdh10, a calcium-dependent adhesion
protein belonging to the non-clustered protocadherin family (Kim etLhx1os and LncMN-1) and their neighboring genes (Lhx1 and Pcdh10) during mESC (left
rmalization vs Atp5o expression levels. B. qRT-PCR analysis of divergent lncRNAs (Lhx1os
o, gray bars), relative to Fus+/+ MNs (wt, black bars), set as 1. Normalization vs Atp5o
178 S. Biscarini et al. / Stem Cell Research 27 (2018) 172–179al., 2011). Pcdh10 mediates homophilic adhesion and it is involved in
neural cells clustering and axon pathfinding (Machado et al., 2014;
Uemura et al., 2007).
In ALS, MN degeneration has been linked to several proteins in-
volved in RNA metabolism. The molecular mechanisms linking gene
mutation to MN degeneration are currently under investigation and
models to discriminate the role of mutated proteins, specifically in
MNs at pre-symptomatic stage,may shed light on the pathogenicmech-
anisms of disease onset. In our work, the use of mESC lines carrying ei-
ther a null or the P517L FUS allele in homozygous conditions, revealed
that three of the conserved lncRNAs (Lhx1os, lncMN-1 and lncMN-2)
are affected by Fus through a loss-of-function mechanism. In the case
of Lhx1os and lncMN-1, the PCGs expressed in divergent orientation
also showed the same trend of deregulation in conditions of Fus deple-
tion ormutation, indicating a co-regulated response to Fus. Since the di-
vergent PCGs have a relevant role in neurogenesis, it will be interesting
to analyze whether the non-coding transcripts work independently
from the PCGs or if they are involved, along with Fus, in controlling
the expression of the divergent gene.
In conclusion, through the use of an in vitro stem cell-based differen-
tiation system, this work provides interesting lncRNA candidates for the
study of new regulatory mechanisms involved in the control of MN dif-
ferentiation or activity, which may contribute to ALS pathogenesis.
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.scr.2018.01.037.
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